Abmaxis - Ownership and Business Overview

Life ScienceCompany

Abmaxis Ownership

Who owns Abmaxis?

Abmaxis is owned by Merck. It was acquired on May 9, 2006.

Abmaxis Business Overview

Where is Abmaxis headquartered?

Abmaxis is headquartered in Santa Clara, California.

What sector is Abmaxis in?

Abmaxis is a life science company.

When was Abmaxis founded?

Abmaxis was founded in 2000.

Life Science M&A Summary in 2006

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2006. The largest life science acquisition in 2006 was Guidant - which was acquired by Boston Scientific for $24.6B.

Join Mergr to view all 120 acquisitions of life science companies in 2006, including 22 acquisitions by private equity firms, and 98 by strategics.

Abmaxis, Inc.

3303 Octavius Drive, Suite 103,
Santa Clara, California 95054
United States,
(408) 988-6100
www.abmaxis.com

Abmaxis, Inc. is a privately-held biopharmaceutical company dedicated to the discovery, optimization and development of monoclonal antibody (MAb) products for human therapeutics and diagnostics. Abmaxis has developed and validated a breakthrough antibody engineering technology platform, Abmaxis in-silico Immunization (AISIM), which is used for building an internal product pipeline and for collaborations with global biotech and pharmaceutical partners. The Company's investors include New World Genomics Ltd. and Y's Therapeutics. Abmaxis is located in Santa Clara, California.


 Subscribe to unlock this and 207,814
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.